Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

OTHER 9 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

apatinib 25 Cisplatin 19 Capecitabine 17 Irinotecan 16 Cyclophosphamide 16 fludarabine 14 Radiotherapy 12 Oxaliplatin 12 Drug Therapy 12 camrelizumab 11 Paclitaxel 11 S 1 (combination) 10 Docetaxel 10 Carboplatin 10 Fluorouracil 9 Blood Specimen Collection 9 Bevacizumab 9 Nivolumab 8 tislelizumab 7 Radiation 7 Pemetrexed 7 Gemcitabine 7 Erlotinib Hydrochloride 7 Surgical Procedures, Operative 6 Neoadjuvant Therapy 6 Albumin-Bound Paclitaxel 6 toripalimab 5 anlotinib 5 XELOX 5 Tamoxifen 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER_GOV × Tyrosine Kinase Inhibitors × Clear all

NCT02794337 2022-04-27

TACE-SBRT

Tata Memorial Hospital

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡